Relaxin-3/RXFP3 networks: an emerging target for the treatment of depression and other neuropsychiatric diseases?

by Craig M Smith, Andrew W Walker, Ihaia T Hosken, Berenice E Chua, Cary eZhang, Mouna eHaidar, Andrew L Gundlach
Published 2014-03-01